Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$FBIO Q2 '26 Earnings Results & Recap Fortress Biotech reported Q1 2026 consolidated net income of $108.4 million, or $2.82 per diluted share, driven by a $205 million priority review voucher sale, compared to a prior year loss.
2
1

Price since post

Full Details
Top Replies
irebelx
The automated Stocktwits earnings account appears to have combined three things incorrectly: FBIO ticker + DERM Q2 transcript + old FBIO Q1 8-K.
irebelx
Just a heads-up: the Stocktwits “FBIO Q2 ’26 Earnings Results” post appears to be mislabeled. The linked 8-K/PDF is actually Fortress Biotech’s Q1 2026 results from May 14, not the new Q2 release. The $108.4M net income / $2.82 diluted EPS figures are Q1 numbers driven by the $205M PRV sale. DERM/Journey Medical did report Q2, but I still don’t see the actual FBIO consolidated Q2 results/10-Q posted yet. Check the document date/title before relying on the automated recap.

Advertisement|Remove ads.